annual FCF:
-$73.24M-$11.82M(-19.24%)Summary
- As of today (August 1, 2025), ELVN annual free cash flow is -$73.24 million, with the most recent change of -$11.82 million (-19.24%) on December 31, 2024.
- During the last 3 years, ELVN annual FCF has fallen by -$53.91 million (-278.97%).
- ELVN annual FCF is now -714.64% below its all-time high of -$8.99 million, reached on December 1, 2020.
Performance
ELVN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$24.15M-$6.94M(-40.37%)Summary
- As of today (August 1, 2025), ELVN quarterly free cash flow is -$24.15 million, with the most recent change of -$6.94 million (-40.37%) on March 31, 2025.
- Over the past year, ELVN quarterly FCF has dropped by -$766.00 thousand (-3.28%).
- ELVN quarterly FCF is now -273.73% below its all-time high of -$6.46 million, reached on September 30, 2022.
Performance
ELVN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$74.00M-$766.00K(-1.05%)Summary
- As of today (August 1, 2025), ELVN TTM free cash flow is -$74.00 million, with the most recent change of -$766.00 thousand (-1.05%) on March 31, 2025.
- Over the past year, ELVN TTM FCF has dropped by -$10.08 million (-15.77%).
- ELVN TTM FCF is now -601.11% below its all-time high of -$10.55 million, reached on March 1, 2022.
Performance
ELVN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ELVN Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.2% | -3.3% | -15.8% |
| 3 y3 years | -279.0% | -128.8% | -601.1% |
| 5 y5 years | -714.6% | - | - |
ELVN Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -279.0% | at low | -273.7% | at low | -311.5% | at low |
| 5 y | 5-year | -714.6% | at low | -273.7% | at low | -601.1% | at low |
| alltime | all time | -714.6% | at low | -273.7% | at low | -601.1% | at low |
ELVN Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$24.15M(+40.4%) | -$74.00M(+1.0%) |
| Dec 2024 | -$73.24M(+19.2%) | -$17.20M(+40.8%) | -$73.24M(+6.9%) |
| Sep 2024 | - | -$12.21M(-40.2%) | -$68.53M(-5.1%) |
| Jun 2024 | - | -$20.44M(-12.6%) | -$72.22M(+13.0%) |
| Mar 2024 | - | -$23.38M(+87.1%) | -$63.92M(+4.1%) |
| Dec 2023 | -$61.42M | -$12.50M(-21.5%) | -$61.42M(+7.4%) |
| Sep 2023 | - | -$15.91M(+31.1%) | -$57.17M(+19.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$12.14M(-41.9%) | -$47.72M(+11.0%) |
| Mar 2023 | - | -$20.88M(+153.2%) | -$43.01M(+31.6%) |
| Dec 2022 | -$32.69M(+69.2%) | -$8.25M(+27.6%) | -$32.69M(+33.7%) |
| Sep 2022 | - | -$6.46M(-13.0%) | -$24.44M(+35.9%) |
| Jun 2022 | - | -$7.43M(-29.6%) | -$17.98M(+70.4%) |
| Mar 2022 | - | -$10.55M | -$10.55M |
| Dec 2021 | -$19.32M(+115.0%) | - | - |
| Dec 2020 | -$8.99M | - | - |
FAQ
- What is Enliven Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual FCF year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Enliven Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM FCF year-on-year change?
What is Enliven Therapeutics, Inc. annual free cash flow?
The current annual FCF of ELVN is -$73.24M
What is the all time high annual FCF for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual free cash flow is -$8.99M
What is Enliven Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, ELVN annual free cash flow has changed by -$11.82M (-19.24%)
What is Enliven Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of ELVN is -$24.15M
What is the all time high quarterly FCF for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly free cash flow is -$6.46M
What is Enliven Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, ELVN quarterly free cash flow has changed by -$766.00K (-3.28%)
What is Enliven Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of ELVN is -$74.00M
What is the all time high TTM FCF for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM free cash flow is -$10.55M
What is Enliven Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, ELVN TTM free cash flow has changed by -$10.08M (-15.77%)